Ability Pharma
Ability Pharma is a first-in-class causing autophagy molecules founded in 2009.
All edits
Edits on 15 Aug, 2024
Ivo Devereux
Edits made to:
Infobox (+5 properties)
Infobox
Edits on 31 Jul, 2024
Ivo Devereux
Edits made to:
Infobox (+7 properties)
Infobox
Email Address
contact@abilitypharma.com
Founded Date
January 1, 2009
Headquarters
Latest Funding Round Date
March 11, 2024
Latest Funding Round Amount (USD)
7,648,868
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
26,911,810
Edits on 6 Feb, 2024
Amy Sar
Edits made to:
Infobox (+3 properties)
Infobox
Email Address
info@neorgsite.com
Industry
Edits on 19 Sep, 2022
Katrina-Kay Pettitt
Edits on 12 Jun, 2022
Golden AI
Edits on 11 Aug, 2021
Aime Anne Nisay
Edits on 10 Aug, 2021
Carla Faraguna
Edits made to:
Ability Pharma
First-in-class causing autophagy molecules
Edits on 3 Aug, 2021
Wyckliffe Otieno
Edits on 3 Aug, 2021
Wyckliffe Otieno
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 4 Jun, 2021
Erin Scherfner
Edits made to:
Infobox (+4 properties)
Description (+42 characters)
Ability Pharma
First-in-class causing autophagy molecules
Infobox
Find more companies like Ability Pharma
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
